Kaplan–Meier survival analysis of clinical data from the CGGA dataset showed that high FABP7 expression was significantly associated with reduced survival in glioma patients (p < 0.001, Figure 3(a)). This evidence concerns the gene FABP7 and central nervous system cancer.